Milton, Christa, and Lydia discussed the impact of tariffs on the life sciences and healthcare industry, particularly on telehealth and remote patient monitoring. They also explored the potential for reshoring manufacturing in America and the financial challenges hospitals face due to Covid and the additional costs of medical devices and pharma. The discussion also covered the impact of international trade and national security on commercial transactions, the potential for export control restrictions, and the impact of tariffs on the healthcare industry, particularly for companies importing products from China.